首页|First-line immunotherapy for advanced non-small cell lung cancer:current progress and future prospects
First-line immunotherapy for advanced non-small cell lung cancer:current progress and future prospects
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
万方数据
Jingyi Wang、Lin Wu
展开 >
The Second Department of Thoracic Oncology,Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine,Central South University,Changsha 410013,China
Xiangya Lung Cancer Center,Xiangya Hospital,Central South University,Changsha 410008,China
Hunan Lung Cancer Clinical Medical Research CenterHunan Science and Technology Innovation ProgramHunan Cancer Hospital Climb plan
NETL
NSTL
万方数据
